1
|
Teruel R, Ponce-Saavedra J, Quijano-Ravell AF. Redescription of Centruroides noxius and description of a closely related new species from western Mexico (Scorpiones: Buthidae). REV MEX BIODIVERS 2015. [DOI: 10.1016/j.rmb.2015.09.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
2
|
Carmo AO, Chatzaki M, Horta CCR, Magalhães BF, Oliveira-Mendes BBR, Chávez-Olórtegui C, Kalapothakis E. Evolution of alternative methodologies of scorpion antivenoms production. Toxicon 2015; 97:64-74. [PMID: 25701676 DOI: 10.1016/j.toxicon.2015.02.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2014] [Revised: 11/10/2014] [Accepted: 02/17/2015] [Indexed: 12/23/2022]
Abstract
Scorpionism represents a serious public health problem resulting in the death of children and debilitated individuals. Scorpion sting treatment employs various strategies including the use of specific medicines such as antiserum, especially for patients with severe symptoms. In 1909 Charles Todd described the production of an antiserum against the venom of the scorpion Buthus quinquestriatus. Based on Todd's work, researchers worldwide began producing antiserum using the same approach i.e., immunization of horses with crude venom as antigen. Despite achieving satisfactory results using this approach, researchers in this field have developed alternative approaches for the production of scorpion antivenom serum. In this review, we describe the work published by experts in toxinology to the development of scorpion venom antiserum. Methods and results describing the use of specific antigens, detoxified venom or toxins, purified toxins and or venom fractions, native toxoids, recombinant toxins, synthetic peptides, monoclonal and recombinant antibodies, and alternative animal models are presented.
Collapse
Affiliation(s)
- A O Carmo
- Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
| | - M Chatzaki
- Department of Molecular Biology & Genetics, Democritus University of Thrace, University Campus, 69100 Komotini, Greece.
| | - C C R Horta
- Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
| | - B F Magalhães
- Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
| | - B B R Oliveira-Mendes
- Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
| | - C Chávez-Olórtegui
- Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
| | - E Kalapothakis
- Departamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
| |
Collapse
|
3
|
Roncolato EC, Campos LB, Pessenda G, Costa e Silva L, Furtado GP, Barbosa JE. Phage display as a novel promising antivenom therapy: A review. Toxicon 2015; 93:79-84. [DOI: 10.1016/j.toxicon.2014.11.001] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2014] [Revised: 09/17/2014] [Accepted: 11/04/2014] [Indexed: 11/15/2022]
|
4
|
Capelli-Peixoto J, Chávez-Olórtegui C, Chaves-Moreira D, Minozzo JC, Gabardo J, Teixeira KN, Thomaz-Soccol V, Alvarenga LM, de Moura J. Evaluation of the protective potential of a Taenia solium cysticercus mimotope on murine cysticercosis. Vaccine 2011; 29:9473-9. [PMID: 22027483 DOI: 10.1016/j.vaccine.2011.10.027] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2011] [Revised: 10/06/2011] [Accepted: 10/10/2011] [Indexed: 10/18/2022]
|
5
|
Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides. Vaccine 2011; 29:7992-8001. [PMID: 21872636 DOI: 10.1016/j.vaccine.2011.08.065] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2011] [Revised: 08/10/2011] [Accepted: 08/12/2011] [Indexed: 11/22/2022]
Abstract
The venom of Loxosceles intermedia (Li) spiders is responsible for cutaneous lesions and other clinical manifestations. We previously reported that the monoclonal antibody LimAb7 can neutralize the dermonecrotic activity of crude Li venom. In this study, we observed that this antibody recognizes several proteins from the venom dermonecrotic fraction (DNF), including LiD1. Identifying the epitope of such a neutralizing antibody could help designing immunogens for producing therapeutic sera or vaccination approaches. To this aim, two sets of 25- and 15-mer overlapping peptides that cover the complete amino acid sequence of LiD1 were synthesized using the SPOT technique. None of them was recognized by LimAb7, suggesting that the epitope is discontinuous. Then, the screening of four peptide phage-display libraries yielded four possible epitope mimics that, however, did not show any obvious similarity with the LiD1 sequence. These mimotopes, together with a 3D model of LiD1, were used to predict with the MIMOP bioinformatic tool the putative epitope region (residues C197, Y224, W225, T226, D228, K229, R230, T232 and Y248 of LiD1) recognized by LimAb7. This analysis and the results of alanine-scanning experiments highlighted a few residues (such as W225 and D228) that are found in the active site of different SMases D and that may be important for LiD1 enzymatic activity. Finally, the only mimotope NCNKNDHLFACW that interacts with LimAb7 by SPOT and its analog NSNKNDHLFASW were used as immunogens in rabbits. The resulting antibodies could neutralize some of the biological effects induced by crude Li venom, demonstrating a mimotope-induced protection against L. intermedia venom.
Collapse
|
6
|
Machado de Avila RA, Stransky S, Velloso M, Castanheira P, Schneider FS, Kalapothakis E, Sanchez EF, Nguyen C, Molina F, Granier C, Chávez-Olórtegui C. Mimotopes of mutalysin-II from Lachesis muta snake venom induce hemorrhage inhibitory antibodies upon vaccination of rabbits. Peptides 2011; 32:1640-6. [PMID: 21763377 DOI: 10.1016/j.peptides.2011.06.028] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2011] [Revised: 06/29/2011] [Accepted: 06/29/2011] [Indexed: 11/24/2022]
Abstract
Mutalysin-II (mut-II) from Lachesis muta snake venom is an endopeptidase with hemorrhagic activity. A mAb against mutalysin-II that neutralized the hemorrhagic effect was produced previously. To identify the mAb epitopes, sets of 15-mer overlapping peptides covering the mut-II amino acid sequence were synthesized using the SPOT method and tested but failed to react with the mAb. Using a phage-display approach seventeen clones reactive with mAb were identified. Additional immunoassays with the peptides and mAb identified the QCTMDQGRLRCR, TCATDQGRLRCT, HCFHDQGRVRCA, HCTMDQGRLRCR and SCMLDQGRSRCR sequences as possible epitopes. Immunization of rabbits with these peptides induced antibodies that recognize mut-II and protected against the hemorrhagic effects of Lachesis venom.
Collapse
Affiliation(s)
- R A Machado de Avila
- Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte-MG, Brazil
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Cardoso R, Homsi-Brandeburgo M, Rodrigues V, Santos W, Souza G, Prudencio C, Siquieroli A, Goulart L. Peptide mimicking antigenic and immunogenic epitope of neuwiedase from Bothrops neuwiedi snake venom. Toxicon 2009; 53:254-61. [DOI: 10.1016/j.toxicon.2008.11.009] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2008] [Revised: 11/14/2008] [Accepted: 11/24/2008] [Indexed: 01/05/2023]
|
8
|
Gazarian KG, Gazarian T, Hernández R, Possani LD. Immunology of scorpion toxins and perspectives for generation of anti-venom vaccines. Vaccine 2005; 23:3357-68. [PMID: 15837360 DOI: 10.1016/j.vaccine.2004.12.027] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2004] [Revised: 08/31/2004] [Accepted: 12/22/2004] [Indexed: 10/25/2022]
Abstract
Scorpions and other venomous animals contain concentrates of biologically active substances developed to block vital physiological and biochemical functions of the victims. These have contrasting human health concerns, provide important pharmacological raw material and pose a serious threat to human life and health in tropical and subtropical regions. Because only occasional and minor quantities of venom are introduced into the human organism with a scorpion sting and their mortal effect is an acute phenomenon these substances are unknown to the immune defense system and thus no immunity has appeared against them during evolution. Antidotes prepared from animal anti-sera are effective against some species of scorpions but depend on the manufacturer and the availability of product to the medical community. Although significant progress has been made in immunological studies of certain groups of toxins, few centers are dedicated to this research. Information is still insufficient to generate a comprehensive picture of the subject and to propose vaccines against venoms. A novel approach based on mimotopes selected from phage-displayed random peptide libraries show potential to impel further progress of toxin immunological studies and to provide putative vaccine resources. In this report we revise the "state of the art" in the field.
Collapse
Affiliation(s)
- Karlen G Gazarian
- Department of Molecular Biology and Biotechnology of Institute of Biomedical Research, Mexican National University (UNAM), Ciudad Universitaria, Circuito escolar s/n, Ciudad Universitaria, 04510 México DF, México.
| | | | | | | |
Collapse
|
9
|
Vacher H, Martin-Eauclaire MF. Antigenic polymorphism of the "short" scorpion toxins able to block K+ channels. Toxicon 2004; 43:447-53. [PMID: 15051409 DOI: 10.1016/j.toxicon.2004.02.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2003] [Accepted: 02/10/2004] [Indexed: 11/16/2022]
Abstract
BmTX3 is a toxin recently characterised from the venom of the Chinese scorpion Buthus martensi Karch, which specifically blocks a transient A-type K+ current in striatum neurons in culture and binds to rat brain synaptosomes with high affinity. With Aa1 and AmmTX3, it belongs to the new alpha-KTx15 subfamily from "short-chain" scorpion toxins, which specifically block different types of K+ channels. Here, a highly specific polyclonal antiserum was raised in rabbit against a C-terminal deleted BmTX3 analogue (BmTX-del YP). Using liquid-phase radioimmunoassay, we have studied its selectivity for the toxins from the alpha-KTx15 subfamily. We have also demonstrated that no/or poor cross-reactivity was observed with a panel of "short-chain" scorpion toxins representative of other structurally different subfamilies. These results suggest that a wide antigenic polymorphism, similar to that previously observed for "long-chain" scorpion toxins acting as modulators of voltage-activated Na+ channels, is also the rule for the "short-chain" scorpion toxins able to block K+ channels.
Collapse
Affiliation(s)
- Hélène Vacher
- CNRS FRE 2738, Laboratoire de Biochimie, Institut Jean Roche, Faculté de Médecine Nord, Université de la Méditerranée, Boulevard Pierre Dramard, 13916 Marseille cedex 20, France
| | | |
Collapse
|